Multiple-dose pharmacokinetics of ritonavir in human immunodeficiency virus-infected subjects.

The multiple-dose pharmacokinetics of ritonavir were investigated in four groups of human immunodeficiency virus-positive male subjects (with 16 subjects per group) under nonfasting conditions; a 3:1 ritonavir:placebo ratio was used. Ritonavir was given at 200 (group I), 300 (group II), 400 (group I...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Hsu, A, Granneman, G R, Witt, G, Locke, C, Denissen, J, Molla, A, Valdes, J, Smith, J, Erdman, K, Lyons, N, Niu, P, Decourt, J P, Fourtillan, J B, Girault, J, Leonard, J M
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1997
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163822/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9145841/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.5.898
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!